Correlating Ic/Pbs Symptoms With Urine Biomarkers
MC
Overseen byMichael Chancellor, MD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: William Beaumont Hospitals
No Placebo Group
Approved in 1 Jurisdiction
Trial Summary
What is the purpose of this trial?
Completion of a brief survey tool and providing an urine specimen. The study purpose is to improve our understanding of interstitial cystitis and painful pelvic syndrome.
Research Team
MC
Michael Chancellor, MD
Principal Investigator
William Beaumont Hospitals
Eligibility Criteria
Inclusion Criteria
Men and women with interstitial cystitis/painful bladder syndrome greater than 18 years old
Male and female controls without a history of IC/PBS diagnosis
1. Unable to complete questionnaires and/or give informed consen
Treatment Details
Interventions
- No intervention (N/A)
Participant Groups
1Treatment groups
Experimental Treatment
Group I: 1Experimental Treatment1 Intervention
patients will be asked to provide a urine specimen and complete a questionnaire.
Find a Clinic Near You
Who Is Running the Clinical Trial?
William Beaumont Hospitals
Lead Sponsor
Trials
153
Recruited
113,000+
Dr. Benjamin Schwartz
William Beaumont Hospitals
Chief Medical Officer since 2021
MD from George Washington University School of Medicine and Health Sciences, Master in Healthcare Management from Harvard University
Tina Freese Decker
William Beaumont Hospitals
Chief Executive Officer since 2022
MBA from Stanford University